Introduction
• Seip-Berardinelli congenital lipodystrophy (SBCL) is an extremely rare autosomal recessive disorder characterized by a congenital absence of adipose tissue.
• Hepatic steatosis, splenomegaly, skeletal muscle hypertrophy, hypertrophic cardiomyopathy, insulin-resistance and diabetes mellitus (DM) are some of the features of such patients.
Discussion
 We report a rare case of lipoatrophic DM in childhood associated with severe insulin-resistance within the context of SBCL. In this setting, DM is frequently difficult to control and the management may involve insulin-sensitizers and exogenous insulin.
 Although the CSII therapy is normally used in insulin-deficient patients, classically type 1 DM, some insulin-resistant DM patients, as the one reported, may benefit from this therapeutical approach. • At 7 years old it was diagnosed DM (fasting plasma glucose= 182mg/dL; HbA1C=8.8%; insulin=116.7mU/L; C-peptide=8.7 ng/mL; HOMA-IR=52.4). He was initially treated with metformin and later at 11 years old with concomitant insulin.
• He had always a poor metabolic control (Figure 2 ) justifying, at 16-years old age the start on continuous subcutaneous insulin infusion (CSII) therapy and a significant improvement was obtained (last HbA1C=8.0%). He is currently under metformin (4 g/day) and CSII therapy (daily dose of insulin of 155U). 
